1. Home
  2. YDDL vs IPSC Comparison

YDDL vs IPSC Comparison

Compare YDDL & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDDL

One and One Green Technologies. Inc Class A Ordinary Shares

N/A

Current Price

$15.34

Market Cap

358.9M

ML Signal

N/A

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.19

Market Cap

370.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDDL
IPSC
Founded
2014
2019
Country
Philippines
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.9M
370.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
YDDL
IPSC
Price
$15.34
$2.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.50
AVG Volume (30 Days)
304.7K
1.4M
Earning Date
05-25-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.85
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$3.61
$0.34
52 Week High
$15.90
$2.97

Technical Indicators

Market Signals
Indicator
YDDL
IPSC
Relative Strength Index (RSI) 71.60 49.37
Support Level $4.77 $1.87
Resistance Level $15.90 $2.68
Average True Range (ATR) 1.94 0.22
MACD 0.35 -0.03
Stochastic Oscillator 89.67 38.97

Price Performance

Historical Comparison
YDDL
IPSC

About YDDL One and One Green Technologies. Inc Class A Ordinary Shares

One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: